Dr. Anders is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Seeley Mudd, 10 Bryan Searle Drive
Durham, NC 27710Phone+1 919-684-8111
Summary
- Dr. Carey K. Anders is the Medical Director of the Duke Brain and Spine Metastases Program and a member of the Neuro-Oncology (primary) and Breast Cancer (secondary) Programs within the Duke Cancer Institute. Dr. Anders is a leading expert in the clinical care of patients with breast cancer of all stages, with a research focus in breast cancer that spreads to the central nervous system (CNS).
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008- Duke University HospitalResidency, Internal Medicine, 2002 - 2005
Brody School of Medicine at East Carolina UniversityClass of 2002
Certifications & Licensure
NC State Medical License 2008 - 2025
Clinical Trials
- Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib Start of enrollment: 2023 Mar 23
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival of Patients With Leptomeningeal Disease.Sujan Niraula, Sugam Gouli, Andrea M Baran, Ruth O'Regan, Haley Tyburski
Clinical Breast Cancer. 2025-01-01 - A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.Danielle M File, Yara Abdou, Jeremy Force, Dominic T Moore, Carey K Anders
Clinical Breast Cancer. 2024-12-01 - Impact of systemic disease on CNS disease control after stereotactic radiosurgery to breast cancer brain metastases (The SYBRA Study).Alex Schick, Sara Hardy, Myla Strawderman, Dandan Zheng, Michael Cummings
NPJ Breast Cancer. 2024-08-02
Press Mentions
Could MRI Help Detect Brain Metastases from Breast Cancer?October 10th, 2022- White Glove Service for Brain and Spine Metastasis PatientsAugust 25th, 2022
- For Small Brain Metastases, Stereotactic Radiosurgery Alone Was Found to Lead to Less Cognitive Deterioration Than Whole Brain Radiotherapy plus the Stereotactic RadiosurgerySeptember 8th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
